Adam Perriman is an Associate Professor of Biomaterials at the School of Cellular and Molecular Medicine, University of Bristol. He is internationally distinguished for his pioneering research on the construction and study of novel synthetic biomolecular systems. His interests are acutely interdisciplinary, built on the solid foundations of fundamental science, and span the fields of chemistry, synthetic biology and regenerative medicine. His significant advances in these areas have resulted in numerous invited presentations at conferences and colloquia, including a plenary lecture at the 2018 Gordon Research Conference on Biointerfaces. He has published a significant proportion of his research in top-tier journals, including Nature Chemistry, Nature Communications, Journal of the American Chemical Society and Advanced Materials. His recent research into the unprecedented development of novel biomaterials has generated extensive media coverage and featured in the popular science magazines New Scientist, Pop Sci and The Royal Society of Chemistry’s Chemistry World. In 2010 and 2016 he was interviewed on BBC4, which was broadcast nationally. In September 2015, he was named a Wellcome Trust's Frontiers Innovator, and in 2016, he received the British Biophysical Society Young Investigator's Award and Medal, which is a national prize awarded to one early career researcher every two years.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.